Zurich Cantonal Bank
XBIT icon

Zurich Cantonal Bank’s XBiotech XBIT Stock Holding History

Zurich Cantonal Bank’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,122
Closed -$18K – 2936
2022
Q1 		$18K Hold
2,122
– – ﹤0.01% 2676
2021
Q4 		$24K Hold
2,122
– – ﹤0.01% 2847
2021
Q3 		$27K Hold
2,122
– – ﹤0.01% 2757
2021
Q2 		$35K Hold
2,122
– – ﹤0.01% 2520
2021
Q1 		$36K Hold
2,122
– – ﹤0.01% 2475
2020
Q4 		$33K Hold
2,122
– – ﹤0.01% 2526
2020
Q3 		$41K Hold
2,122
– – ﹤0.01% 2313
2020
Q2 		$29K Buy
+2,122
New +$29.8K ﹤0.01% 2375

Other funds holding XBIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Zurich Cantonal Bank's XBIT Position: Q2 2022 in Review

Zurich Cantonal Bank sold out of XBiotech (XBIT) in Q2 2022, closing a stake of 2,122 shares — an estimated $18K sold.

Zurich Cantonal Bank first reported a position in XBIT in Q2 2020 and held it in 8 quarters. The position peaked at $41K in Q3 2020. 56 funds tracked by Wall St. Rank hold XBIT as of Q2 2022.

  • Zurich Cantonal Bank reported no remaining XBiotech position as of Q2 2022 after selling out during the quarter.
  • Zurich Cantonal Bank sold 2,122 XBiotech shares in Q2 2022, an estimated $18K.
  • Zurich Cantonal Bank first reported a position in XBiotech in Q2 2020 and held it in 8 quarters.
  • Zurich Cantonal Bank's XBiotech position peaked at $41K in Q3 2020.
  • 56 funds tracked by Wall St. Rank held XBiotech as of Q2 2022.

Based on Zurich Cantonal Bank's 13F filing for Q2 2022, filed 9 Aug 2022.